ArticleClinical kidney journal2023

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab.

Savino Sciascia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.